Scarica l'app Stockscreener
67.55
2.04%
1.22
Dopo l'orario di chiusura:
67.56
0.01
+0.01%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DXCM Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$66.33
Aprire:
$66.485
Volume 24 ore:
6.06M
Relative Volume:
0.96
Capitalizzazione di mercato:
$26.35B
Reddito:
$4.30B
Utile/perdita netta:
$571.50M
Rapporto P/E:
47.29
EPS:
1.4285
Flusso di cassa netto:
$570.80M
1 W Prestazione:
+4.37%
1M Prestazione:
+23.42%
6M Prestazione:
-20.20%
1 anno Prestazione:
-14.77%
Intervallo 1D:
$65.61
$68.22
Intervallo di 1 settimana:
$64.00
$68.22
Portata 52W:
$54.11
$93.25
Dexcom Inc Stock (DXCM) Company Profile
Nome
Dexcom Inc
Settore
Industria
Telefono
(858) 200-0200
Indirizzo
6340 SEQUENCE DRIVE, SAN DIEGO, CA
Confronta DXCM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
67.55 | 25.87B | 4.30B | 571.50M | 570.80M | 1.4285 |
|
ABT
Abbott Laboratories
|
122.55 | 210.84B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
92.69 | 137.17B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
353.68 | 133.55B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
100.76 | 127.71B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
83.94 | 48.33B | 5.88B | 1.34B | 799.60M | 2.3489 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | Iniziato | Evercore ISI | In-line |
| 2025-10-21 | Ripresa | Stifel | Buy |
| 2025-09-08 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-08-21 | Iniziato | Argus | Buy |
| 2025-06-16 | Iniziato | Truist | Buy |
| 2025-05-30 | Iniziato | Goldman | Buy |
| 2025-04-10 | Iniziato | Mizuho | Outperform |
| 2025-02-03 | Aggiornamento | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-26 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | Iniziato | Redburn Atlantic | Neutral |
| 2024-03-12 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-04-17 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2023-01-26 | Iniziato | Wolfe Research | Outperform |
| 2022-10-18 | Iniziato | Barclays | Equal Weight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-15 | Iniziato | Bernstein | Outperform |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-03 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-01-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2021-10-18 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-07-21 | Ripresa | Cowen | Outperform |
| 2021-05-28 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2021-01-06 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-02 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | Reiterato | Piper Sandler | Overweight |
| 2020-05-14 | Iniziato | Wells Fargo | Equal Weight |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-11-07 | Reiterato | Canaccord Genuity | Buy |
| 2019-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-10-23 | Iniziato | Stifel | Buy |
| 2018-11-28 | Iniziato | UBS | Neutral |
| 2018-10-19 | Aggiornamento | Goldman | Sell → Neutral |
| 2018-09-12 | Aggiornamento | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | Reiterato | Canaccord Genuity | Buy |
| 2018-07-02 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2018-05-11 | Iniziato | BofA/Merrill | Buy |
| 2018-05-03 | Reiterato | Canaccord Genuity | Buy |
| 2018-04-04 | Iniziato | Goldman | Sell |
| 2018-04-04 | Iniziato | Guggenheim | Neutral |
| 2018-03-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | Downgrade | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | Reiterato | Wedbush | Outperform |
Mostra tutto
Dexcom Inc Borsa (DXCM) Ultime notizie
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Holzer & Holzer, LLC Reminds Investors of Upcoming Lead - GlobeNewswire
DexCom, Inc. (DXCM) Shareholders Get Answers in Latest SueWallSt Podcast - ACCESS Newswire
Bank of Nova Scotia Sells 400,824 Shares of DexCom, Inc. $DXCM - Defense World
8-Day Rally Sends DexCom Stock Up 6.4% - Trefis
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against DexCom and CarMax and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
DEXCOM, INC. (NASDAQ: DXCM) SHAREHOLDER ALERT Bernstein - GlobeNewswire
DexCom, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before December 26, 2025 to Discuss Your RightsDXCM - cnhinews.com
DexCom, Inc. $DXCM Holdings Decreased by Brown Advisory Inc. - Defense World
Lost Money on DexCom, Inc. (DXCM)? Contact Levi & Korsinsky to Join Class Action Before December 26, 2025 - Stockhouse
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Is DexCom Stock Underperforming the S&P 500? - MSN
DXCM SHAREHOLDER ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against DexCom, Inc. (DXCM) - PR Newswire
Shareholders SueWallSt in New Class Action Against DexCom, Inc.Act Now - Nasdaq
HALPER SADEH LLC ENCOURAGES DEXCOM, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS - PR Newswire
Lowey Dannenberg Notifies DexCom, Inc. (“DexCom” or the - GlobeNewswire
SueWallSt Podcast Series Launches With Focus on DexCom, Inc. (DXCM) Fraud Allegations - ACCESS Newswire
DXCM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
DexCom, Inc. $DXCM Shares Acquired by Marshall Wace LLP - MarketBeat
How DexCom Inc. (DC4) stock trades after rate cutsJuly 2025 Analyst Calls & Advanced Technical Analysis Signals - Newser
Baird Financial Group Inc. Sells 49,243 Shares of DexCom, Inc. $DXCM - Defense World
Is DexCom Inc. (DC4) stock cheap by valuation metricsQuarterly Profit Review & Daily Oversold Bounce Ideas - Newser
Bragar Eagel & Squire, P.C. Urges DexCom and Wildermuth - GlobeNewswire
DXCM Deadline Approaching on December 26, 2025: Kessler - GlobeNewswire
Key facts: Class Action Filed Against DexCom; Company Launches Academy - TradingView
Edgestream Partners L.P. Increases Position in DexCom, Inc. $DXCM - Defense World
Listening to healthcare professionals: Dexcom launches new education offering, Dexcom Academy - marketscreener.com
Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy - Eagle-Tribune
Investors SueWallSt as DexCom, Inc. Faces Securities Fraud Allegations - Nasdaq
The Gross Law Firm Notifies Shareholders of DexCom, - GlobeNewswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Isthmus Partners LLC Takes $14.61 Million Position in DexCom, Inc. $DXCM - MarketBeat
Groupe la Francaise Increases Stock Holdings in DexCom, Inc. $DXCM - MarketBeat
Fisher Asset Management LLC Decreases Holdings in DexCom, Inc. $DXCM - MarketBeat
How DexCom Inc. (DC4) stock trades after earnings2025 Earnings Surprises & High Return Stock Watch Alerts - Newser
Investors SueWallSt Over DexCom, Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
DXCM DEADLINE: DexCom, Inc. Investors Encouraged to Contact Kirby McInerney LLP Before Looming Deadline in Lawsuit - ACCESS Newswire
Morgan Stanley Upgrades DexCom (DXCM) - Nasdaq
DXCM DEADLINE: ROSEN, TOP RANKED INVESTOR COUNSEL, - GlobeNewswire
DexCom, Inc. (DXCM) Investors: December 26, 2025 Filing Deadline in Securities Class ActionContact Kessler Topaz Meltzer & Check, LLP - NewMediaWire
DexCom (DXCM): Morgan Stanley Upgrades Rating to Overweight and - GuruFocus
DexCom Stock Upgraded. How the Glucose Monitor Maker Is ‘Turning a Corner.’ - Barron's
DexCom (DXCM) Upgraded by Morgan Stanley with Increased Price Ta - GuruFocus
DexCom upgraded at Morgan Stanley on sorting out operational issues - Seeking Alpha
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom LawsuitDXCM - PR Newswire
XTX Topco Ltd Lowers Stock Position in DexCom, Inc. $DXCM - MarketBeat
Analyst recommendations: Albemarle, Dexcom, T-Mobile, Alphabet, Micron… - marketscreener.com
Morgan Stanley Upgrades DexCom to Overweight From Equalweight, Adjusts PT to $75 From $63 - marketscreener.com
Advisors Asset Management Inc. Sells 1,259 Shares of DexCom, Inc. $DXCM - Defense World
Dexcom Inc Azioni (DXCM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):